MedPath

Feasibility Study: Sleuth Monitoring System

Not Applicable
Conditions
Arrhythmia
Syncope
Registration Number
NCT00719277
Lead Sponsor
Transoma Medical
Brief Summary

The purpose of the study is to evaluate the safety and performance of the Sleuth Monitoring system.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age > = 18 years at time of enrollment

  • Either of the following:

    1. MI > 30 days prior to enrolment and LVEF < = 35% by echocardiography (or nuclear imaging as necessary)
    2. Syncope of unknown etiology
Exclusion Criteria
  • Life expectancy < 12 months following enrollment
  • Active infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Diagnostically viable ECG signalsdaily
Secondary Outcome Measures
NameTimeMethod
rate of device-related adverse events1, 6, and 12 months

Trial Locations

Locations (1)

Hospital Paitilla

🇵🇦

Panama city, Panama

© Copyright 2025. All Rights Reserved by MedPath